loadpatents
Patent applications and USPTO patent grants for Espina; Virginia.The latest application filed is for "compositions and methods for laser capture microdissection".
Patent | Date |
---|---|
Dual inhibitory action peptidomimetic inhibitor for IL-33 and IL-1beta Grant 10,927,155 - Liotta , et al. February 23, 2 | 2021-02-23 |
Compositions And Methods For Laser Capture Microdissection App 20200333220 - LIOTTA; Lance ;   et al. | 2020-10-22 |
Compositions and methods for laser capture microdissection Grant 10,697,866 - Liotta , et al. | 2020-06-30 |
Dual Inhibitory Action Peptidomimetic Inhibitor For Il-33 And Il-1beta App 20190352351 - LIOTTA; Lance ;   et al. | 2019-11-21 |
Compositions And Methods For Laser Capture Microdissection App 20190250079 - LIOTTA; LANCE ;   et al. | 2019-08-15 |
Compositions and methods for laser capture microdissection Grant 10,324,008 - Liotta , et al. | 2019-06-18 |
Binding Domain Mapping App 20190033319 - Luchini; Alessandra ;   et al. | 2019-01-31 |
Binding domain mapping Grant 10,126,304 - Luchini , et al. November 13, 2 | 2018-11-13 |
Compositions and Methods For Laser Capture Microdissection App 20170176301 - Liotta; Lance ;   et al. | 2017-06-22 |
Binding Domain Mapping App 20150338417 - Luchini; Alessandra ;   et al. | 2015-11-26 |
Methods of treating pre-malignant ductal cancer with autophagy inhibitors Grant 9,096,833 - Espina , et al. August 4, 2 | 2015-08-04 |
Phosphorylated C-ErbB2 as a superior predictive theranostic marker for the diagnosis and treatment of cancer Grant 9,086,414 - Petricoin, III , et al. July 21, 2 | 2015-07-21 |
Hydrogel nanoparticle based immunoassay Grant 9,012,240 - Liotta , et al. April 21, 2 | 2015-04-21 |
mTOR pathway theranostic Grant 8,628,931 - Liotta , et al. January 14, 2 | 2014-01-14 |
Smart hydrogel particles for biomarker harvesting Grant 8,497,137 - Luchini , et al. July 30, 2 | 2013-07-30 |
Smart Hydrogel Particles for Biomarker Harvesting App 20120164749 - Luchini; Alessandra ;   et al. | 2012-06-28 |
Bait Chemistries In Hydrogel Particles For Serum Biomarker Analysis App 20120107959 - Liotta; Lance ;   et al. | 2012-05-03 |
Glioblastoma Biomarkers, and Methods and Compositions App 20120083422 - Mueller; Claudius ;   et al. | 2012-04-05 |
Modulation of autophagy and and serotonin for treatment of multiple myeloma related diseases App 20120076770 - Espina; Virginia ;   et al. | 2012-03-29 |
Malignant Precursor Cells From Ductal Carcinoma In Situ Lesions App 20120077843 - Liotta; Lance A. ;   et al. | 2012-03-29 |
Bone Modulators And Methods Therewith App 20120065166 - Espina; Virginia ;   et al. | 2012-03-15 |
Hydrogel Nanoparticle Based Immunoassay App 20110236999 - Liotta; Lance A. ;   et al. | 2011-09-29 |
Ex Vivo Therapeutics Screening Of Living Bone Marrow Cells For Multiple Myeloma App 20110207627 - Liotta; Lance A. ;   et al. | 2011-08-25 |
PHOSPHORYLATED C-ErbB2 AS A SUPERIOR PREDICTIVE THERANOSTIC MARKER FOR THE DIAGNOSIS AND TREATMENT OF CANCER App 20110189173 - Petricoin, III; Emanuel F. ;   et al. | 2011-08-04 |
Genetic Alteration Associated With Pre-malignant Cancer App 20110104065 - Espina; Virginia ;   et al. | 2011-05-05 |
Post-exposure Prophylaxis And Treatment Of Infections App 20110046039 - Popov; Serguei G. ;   et al. | 2011-02-24 |
Biomarkers For Neurological Conditions App 20100159486 - Liotta; Lance A. ;   et al. | 2010-06-24 |
Mtor Pathway Theranostic App 20090148859 - Liotta; Lance A ;   et al. | 2009-06-11 |
Ocular fluid markers App 20070224644 - Liotta; Lance A. ;   et al. | 2007-09-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.